IDEAS home Printed from https://ideas.repec.org/d/cermmit.html

Publications

by members of

CERM - Competitività, Regole, Mercati

CERM - Competitivity, Rules, Markets

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Working papers | Journal articles | Books | Chapters |

Working papers

2020

  1. Selene Perazzini & Giorgio Stefano Gnecco & Fabio Pammolli, 2020, "A Public-Private Insurance Model for Natural Risk Management: an Application to Seismic and Flood Risks on Residential Buildings in Italy," Papers, arXiv.org, number 2006.05840, Jun.

2019

  1. Fabio Pammolli & Paolo Bonaretti & Massimo Riccaboni & Valentina Tortolini, 2019, "Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2019, Nov.

2018

  1. Spelta, Alessandro & Pecora, Nicolò & Flori, Andrea & Pammolli, Fabio, 2018, "Transition drivers and crisis signaling in stock markets," MPRA Paper, University Library of Munich, Germany, number 88127, Jul.
  2. Andrea Flori & Fabrizio Lillo & Fabio Pammolli & Alessandro Spelta, 2018, "Better to stay apart: asset commonality, bipartite network centrality, and investment strategies," Papers, arXiv.org, number 1811.01624, Nov.

2017

  1. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Monica Auteri & Guido Borà, 2017, "La spesa sanitaria delle Regioni in Italia - Saniregio2017," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2017, May.
  2. Bendetta Frassi & Christian Hagist & Fabio Pammolli, 2017, "Who is this, who enters there? - Migration in Italy and its effect on fiscal sustainability and pensions," WHU Working Paper Series - Economics Group, WHU - Otto Beisheim School of Management, number 17-01, Jan.
  3. Benedetta Frassi & Fabio Pammolli & Luca Regis, 2017, "The potential costs of Longevity Risk on Public Pensions. Evidence from Italian data," Working Papers, IMT School for Advanced Studies Lucca, number 01/2017, Jan, revised Jan 2017.
  4. Armando Rungi & Gregory Morrison & Fabio Pammolli, 2017, "Global ownership and corporate control networks," Working Papers, IMT School for Advanced Studies Lucca, number 07/2017, Sep, revised Sep 2017.

2016

  1. Andrea Flori & Simone Giansante & Fabio Pammolli, 2016, "Peer-Group Detection of Banks and Resilience to Distress," Working Papers, IMT School for Advanced Studies Lucca, number 06/2016, Dec, revised Dec 2016.
  2. Andrea Flori & Giuseppe Pappalardo & Michelangelo Puliga & Alessandro Chessa & Fabio Pammolli, 2016, "The Accounting Network: how financial institutions react to systemic crisis," Papers, arXiv.org, number 1605.01976, May.
  3. Fabio Pammolli & Armando Rungi, 2016, "Access to Medicines and European Market Integration," Working Papers, IMT School for Advanced Studies Lucca, number 01/2016, Jan, revised Jan 2016.

2015

  1. Michele Bonollo & Irene Crimaldi & Andrea Flori & Fabio Pammolli & Massimo Riccaboni, 2015, "Systemic risk and banking regulation: some facts on the new regulatory framework," Working Papers, IMT School for Advanced Studies Lucca, number 1/2015, Jan, revised Jan 2015.
  2. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Guido Borà, 2015, "La spesa sanitaria delle Regioni in Italia - Saniregio 2015," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2015, Aug, revised 04 Jan 2016.
  3. Michele Bonollo & Irene Crimaldi & Andrea Flori & Laura Gianfagna & Fabio Pammolli, 2015, "Assessing financial distress dependencies in OTC markets: a new approach by Trade Repositories data," Working Papers, IMT School for Advanced Studies Lucca, number 10/2015, Oct, revised Oct 2015.

2014

  1. Laura Magazzini & Fabio Pammolli & Valentina Tortolini, 2014, "Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2014, Mar.
  2. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Guido Borà, 2014, "La spesa sanitaria delle Regioni in Italia - Saniregio 3," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2014, Dec.
  3. Michele Bonollo & Irene Crimaldi & Andrea Flori & Fabio Pammolli & Massimo Riccaboni, 2014, "Systemic importance of financial institutions: from a global to a local perspective? A network theory approach," Working Papers, IMT School for Advanced Studies Lucca, number 9/2014, Sep, revised Sep 2014.
  4. Michele Bonollo & Irene Crimaldi & Andrea Flori & Fabio Pammolli & Massimo Riccaboni, 2014, "Systemic importance of financial institutions: regulations, research, open issues, proposals," Working Papers, IMT School for Advanced Studies Lucca, number 2/2014, Mar, revised Mar 2014.
  5. Andrea Morescalchi & Fabio Pammolli & Orion Penner & Alexander M. Petersen & Massimo Riccaboni, 2014, "The evolution of networks of innovators within and across borders: Evidence from patent data," Working Papers, IMT School for Advanced Studies Lucca, number 1/2014, Jan, revised Jan 2014.

2013

  1. Magazzini Laura & Fabio Pammolli & Massimo Riccaboni, 2013, "R&D, Within and Between Patent Competition in the Pharmaceutical Industry," Working Papers, IMT School for Advanced Studies Lucca, number 3/2013, Jul, revised Jul 2013.
  2. Andrea Morescalchi & Fabio Pammolli & Orion Penner & Petersen Alexander M. & Massimo Riccaboni, 2013, "Networks of innovators within and across borders. Evidence from patent data," Working Papers, IMT School for Advanced Studies Lucca, number 4/2013, Aug, revised Aug 2013.
  3. Fabio Pammolli, 2013, "Demography, Sustainability, and Growth Notes on the future of the European "Social Market" Economy," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2013, Oct.

2012

  1. Salerno, Nicola Carmine & Pammolli, Fabio, 2012, "La Riforma del Welfare, il Paygo, i nuovi Ammortizzatori per il Mercato del Lavoro
    [Reform of Welfare System, Scale of functioning of PayGo, and development of modern Unemployment Benefits]
    ," MPRA Paper, University Library of Munich, Germany, number 38396, Apr, revised 15 Apr 2012.
  2. Pammolli, Fabio & Salerno, Nicola, 2012, "La Sostenibilità dei Sistemi Sanitari Regionali
    [The Financial Sustainability of Italian Regional Health Care Systems]
    ," MPRA Paper, University Library of Munich, Germany, number 36927, Feb.
  3. Fabio Pammolli & Nicola Carmine Salerno, 2012, "La Sostenibilità dei Sistemi Sanitari Regionali - SaniMod-Reg 2012-2030," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2012, Feb.
  4. Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2012, "I Farmaci Oncologici in Italia: innovazione e sostenibilità economica," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2012, Jun.
  5. Jing-Yuan Chio & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2012, "The Value of Failures in Pharmaceutical R&D," Working Papers, IMT School for Advanced Studies Lucca, number 1/2012, Jan, revised Jan 2012.

2011

  1. Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011, "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper, University Library of Munich, Germany, number 30046, Mar.
  2. Pammolli, Fabio & Salerno, Nicola, 2011, "Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM
    [Regional differences in the governance of health care expenditure. Italian Health Care System (Ssn) in the transiti
    ," MPRA Paper, University Library of Munich, Germany, number 36934.
  3. Pammolli, Fabio & Salerno, Nicola, 2011, "The Multipillar System for Health Care Financing: Thirteen Good Reasons for Open Capitalisation Funds, Covering both Pension and Health Care Provisions," MPRA Paper, University Library of Munich, Germany, number 36928.
  4. Fabio Pammolli & Nicola Carmine Salerno, 2011, "Federalismo e riparto del Fsn-2011: Much Ado About Nothing?," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2011, Apr.
  5. Fabio Pammolli & Nicola Carmine Salerno, 2011, "Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2011, Jun.
  6. Fabio Pammolli & Nicola Carmine Salerno, 2011, "Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2011, Dec.

2010

  1. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2010, "The productivity crisis in pharmaceutical R&D," Working Papers, University of Verona, Department of Economics, number 06/2010, Apr.
  2. Fabio Pammolli & Nicola Carmine Salerno, 2010, "I numeri del federalismo: una simulazione per la sanità," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2010, Jun.
  3. Fabio Pammolli & Nicola Carmine Salerno, 2010, "I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2010, Aug.
  4. Fabio Pammolli & Nicola Carmine Salerno, 2010, "I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2010, Nov.
  5. Fabio Pammolli & Nicola Carmine Salerno, 2010, "La regolamentazione delle farmacie in Italia," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 04-2010, Nov.
  6. Fabio Pammolli & Nicola Carmine Salerno, 2010, "L'integrazione pubblico-privato in sanità e assistenza alla persona," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 05-2010, Jul.
  7. Fabio Pammolli & Nicola Carmine Salerno, 2010, "I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 06-2010, Jun.

2009

  1. Massimo Riccaboni & Fabio Pammolli & Sergey V. Buldyrev & Linda Ponta & H. Eugene Stanley, 2009, "The Size Variance Relationship of Business Firm Growth Rates," ROCK Working Papers, Department of Computer and Management Sciences, University of Trento, Italy, number 052, Jun, revised 11 Jun 2009.
  2. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009, "Patent Disclosure and R&D Competition in Pharmaceuticals," ROCK Working Papers, Department of Computer and Management Sciences, University of Trento, Italy, number 053, Jun, revised 11 Jun 2009.
  3. Davide Integlia & Fabio Pammolli, 2009, "I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2009, Jan.
  4. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2009, "Nuove politiche per l'innovazione nel settore delle scienze della vita," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2009, Mar.
  5. Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2009, "La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2009, Nov.
  6. Fabio Pammolli & Massimo Riccaboni, 2009, "Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 04-2009, Dec.

2008

  1. Maksim Kitsak & Massimo Riccaboni & Shlomo Havlin & Fabio Pammolli & H. Eugene Stanley, 2008, "Structure of Business Firm Networks and Scale-Free Models," ROCK Working Papers, Department of Computer and Management Sciences, University of Trento, Italy, number 051, Dec, revised 16 Jan 2009.
  2. Pammolli, Fabio & Riccaboni, Massimo & Magazzini, Laura, 2008, "The Sustainability of European Health Care Systems: Beyond Income and Ageing," MPRA Paper, University Library of Munich, Germany, number 16026, Oct.
  3. Fabio Pammolli & Nicola Carmine Salerno, 2008, "Inflazione, bassa crescita, Euro forte: tra problemi europei ed economia globale," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2008, Jul.
  4. Fabio Pammolli & Nicola Carmine Salerno, 2008, "Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2008, Oct.
  5. Fabio Pammolli & Nicola Carmine Salerno, 2008, "La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2008, May.
  6. Roberto Cicciomessere & Fabio Pammolli & Nicola Carmine Salerno, 2008, "Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 04-2008, Oct.
  7. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2008, "Patent Value and R&D Competition," Working Papers, University of Verona, Department of Economics, number 51/2008, Oct.

2007

  1. Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene, 2007, "Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks," MPRA Paper, University Library of Munich, Germany, number 15907, May.
  2. Arora, Ashish & Gambardella, Alfonso & Magazzini, Laura & Pammolli, Fabio, 2007, "A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development," MPRA Paper, University Library of Munich, Germany, number 16042, Mar.
  3. Pammolli, Fabio & Cambini, Carlo & Giannaccari, Andrea, 2007, "Introduzione. Liberalizzazioni e concorrenza in Italia
    [Introduction. Liberalisation and competition in Italy]
    ," MPRA Paper, University Library of Munich, Germany, number 16125.
  4. Fabio Pammolli & Nicola Carmine Salerno, 2007, "La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2007, Oct.
  5. Chiara Bonassi & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007, "Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2007, Oct.
  6. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007, "La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2007, Oct.
  7. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007, "Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 04-2007, Dec.

2006

  1. Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2006, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," MPRA Paper, University Library of Munich, Germany, number 15983, Aug.
  2. Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene, 2006, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," MPRA Paper, University Library of Munich, Germany, number 15980, Aug.
  3. Fabio Pammolli & Nicola Carmine Salerno, 2006, "La nuova fiscalità della previdenza complementare per il lavoratore, l'impresa e l'Erario - Una quantificazione per il lavoratore dipendente neoassunto del settore privato con turnover decennale di datore di lavoro," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2006, Feb.
  4. Fabio Pammolli & Nicola Carmine Salerno, 2006, "Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2006, Feb.
  5. Laura Magazzini & Fabio Pammolli & Nicola Carmine Salerno, 2006, "La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2006, Jun.

2005

  1. Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2005, "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," MPRA Paper, University Library of Munich, Germany, number 15905.
  2. Pammolli, Fabio & Riccaboni, Massimo & Oglialoro, Claudia & Magazzini, Laura & Baio, Gianluca & Salerno, Nicola, 2005, "Medical Devices Competitiveness and Impact on Public Health Expenditure," MPRA Paper, University Library of Munich, Germany, number 16021, Jul.
  3. Kaushik Matia & Dongfeng Fu & Sergey V. Buldyrev & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2005, "Statistical Properties of Business Firms Structure and Growth," Papers, arXiv.org, number physics/0502081, Feb.
  4. Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2005, "Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2005, Feb.
  5. Fabio Pammolli & Nicola Carmine Salerno, 2005, "Il disegno delle nuove agevolazioni fiscali alla previdenza complementare - una quantificazione per un lavoratore dipendente neoassunto del settore privato," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2005, Aug.
  6. Fabio Pammolli & Nicola Carmine Salerno, 2005, "Opting-out previdenziale, smobilizzo del TFR e basi strutturali del pilastro privato," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 04-2005, Nov.
  7. Fabio Pammolli & Nicola Carmine Salerno, 2005, "Alcuni vantaggi "minori" del contributivo: Ricongiunzione e Totalizzazione," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2005, Jul.

2004

  1. Yamasaki, Kazuko & Matia, Kaushik & Buldyrev, Sergey V. & Fu, Dongfeng & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene, 2004, "Preferential attachment and growth dynamics in complex systems," MPRA Paper, University Library of Munich, Germany, number 15908, Jun, revised 06 Feb 2006.
  2. Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo, 2004, "Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure," MPRA Paper, University Library of Munich, Germany, number 15968, Feb.
  3. Pammolli, Fabio & Riccaboni, Massimo, 2004, "Market Structure and Drug Innovation," MPRA Paper, University Library of Munich, Germany, number 16212.
  4. Fabio Pammolli & Nicola Carmine Salerno, 2004, "Gli andamenti della spesa sanitaria: l'Italia in una sintetica comparazione internazionale," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 01-2004, Jan.
  5. Fabio Pammolli & Nicola Carmine Salerno, 2004, "Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 02-2004, Mar.
  6. Claudia Oglialoro & Fabio Pammolli & Nicola Carmine Salerno, 2004, "Strumenti di regolazione del mercato farmaceutico: un'analisi ragionata," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 03-2004, Jul.
  7. Marianna Madia & Fabio Pammolli & Nicola Carmine Salerno, 2004, "In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 04-2004, Jun.
  8. Fabio Pammolli & Pietro Rizza & Nicola Carmine Salerno, 2004, "Regole pensionistiche e incentivi al prolungamento della vita lavorativa: analisi del caso italiano," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 06-2004, Apr.
  9. Fabio Pammolli & Nicola Carmine Salerno, 2004, "Regole pensionistiche e prolungamento dell'attività: analisi del TIR e effetti del cumulo lavoro-pensione," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 07-2004, Jun.

2003

  1. De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio, 2003, "On Size and Growth of Business Firms," MPRA Paper, University Library of Munich, Germany, number 15866, Mar.
  2. Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni, 2003, "Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato," Working Papers CERM, Competitività, Regole, Mercati (CERM), number 0-2003, Jan.

2001

  1. Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2001, "A Comparison of U.S. And European University-Industry Relations in the Life Sciences," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2001/03, Dec.
  2. Giulio Bottazzi & Giovanni Dosi & Marco Lippi & Fabio Pammolli & Massimo Riccaboni, 2001, "Innovation and Corporate Growth in the Evolution of the Drug Industry," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2001/02, Dec.
  3. Fabio Pammolli & Massimo Riccaboni, 2001, "Technological Regimes and the Growth of Networks An Empirical Analysis," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2001/07, Dec.
  4. Riccaboni, Massimo & Pammolli, Fabio, 2001, "On Firm Growth in Networks," MPRA Paper, University Library of Munich, Germany, number 15964, Oct, revised 12 Nov 2001.

2000

  1. Giulio Bottazzi & Giovanni Dosi & Marco Lippi & Fabio Pammolli & Massimo Riccaboni, 2000, "Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2000/05, Dec.
  2. Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000, "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper, University Library of Munich, Germany, number 15965, Nov.
  3. Arora, Ashish & Gambardella, Alfonso & Pammolli, Fabio & Riccaboni, Massimo, 2000, "The Nature and the Extent of the Market for Technology in Biopharmaceuticals," MPRA Paper, University Library of Munich, Germany, number 15977, Dec.

1999

  1. Fabio Pammolli & Massimo Riccaboni, 1999, "Networks Dynamics in the Pharmaceutical Industry," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 1999/18, Nov.
  2. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999, "Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 1999/13, Nov.
  3. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999, "Co-evolution of Organizational Forms and Technology," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 1999/16, Nov.
  4. Andrea Bonaccorsi & Thomas Lyon & Fabio Pammolli & Giuseppe Turchetti, 1999, "Auctions vs. Bargaining: An Empirical Analysis of Medical Device Procurement," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 1999/20, Nov.

Journal articles

2022

  1. Scotti, Francesco & Flori, Andrea & Pammolli, Fabio, 2022, "The economic impact of structural and Cohesion Funds across sectors: Immediate, medium-to-long term effects and spillovers," Economic Modelling, Elsevier, volume 111, issue C, DOI: 10.1016/j.econmod.2022.105833.
  2. Giorgio Gnecco & Fabio Pammolli & Berna Tuncay, 2022, "Welfare and research and development incentive effects of uniform and differential pricing schemes," Computational Management Science, Springer, volume 19, issue 2, pages 229-268, June, DOI: 10.1007/s10287-021-00414-8.
  3. Pagnottoni, Paolo & Spelta, Alessandro & Flori, Andrea & Pammolli, Fabio, 2022, "Climate change and financial stability: Natural disaster impacts on global stock markets," Physica A: Statistical Mechanics and its Applications, Elsevier, volume 599, issue C, DOI: 10.1016/j.physa.2022.127514.

2021

  1. Spelta, A. & Flori, A. & Pecora, N. & Pammolli, F., 2021, "Financial crises: Uncovering self-organized patterns and predicting stock markets instability," Journal of Business Research, Elsevier, volume 129, issue C, pages 736-756, DOI: 10.1016/j.jbusres.2019.10.043.
  2. Andrea Flori & Simone Giansante & Claudia Girardone & Fabio Pammolli, 2021, "Banks’ business strategies on the edge of distress," Annals of Operations Research, Springer, volume 299, issue 1, pages 481-530, April, DOI: 10.1007/s10479-019-03383-z.
  3. Andrea Flori & Fabrizio Lillo & Fabio Pammolli & Alessandro Spelta, 2021, "Better to stay apart: asset commonality, bipartite network centrality, and investment strategies," Annals of Operations Research, Springer, volume 299, issue 1, pages 177-213, April, DOI: 10.1007/s10479-019-03277-0.
  4. Pagnottoni, Paolo & Spelta, Alessandro & Pecora, Nicolò & Flori, Andrea & Pammolli, Fabio, 2021, "Financial earthquakes: SARS-CoV-2 news shock propagation in stock and sovereign bond markets," Physica A: Statistical Mechanics and its Applications, Elsevier, volume 582, issue C, DOI: 10.1016/j.physa.2021.126240.
  5. Flori, Andrea & Pammolli, Fabio & Spelta, Alessandro, 2021, "Commodity prices co-movements and financial stability: A multidimensional visibility nexus with climate conditions," Journal of Financial Stability, Elsevier, volume 54, issue C, DOI: 10.1016/j.jfs.2021.100876.
  6. Fabio Pammolli & Massimo Riccaboni & Alessandro Spelta, 2021, "The network origins of Schumpeterian innovation," Journal of Evolutionary Economics, Springer, volume 31, issue 5, pages 1411-1431, November, DOI: 10.1007/s00191-021-00733-8.

2020

  1. Giovanni Bonaccorsi & Francesco Pierri & Matteo Cinelli & Andrea Flori & Alessandro Galeazzi & Francesco Porcelli & Ana Lucia Schmidt & Carlo Michele Valensise & Antonio Scala & Walter Quattrociocchi , 2020, "Economic and social consequences of human mobility restrictions under COVID-19," Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, volume 117, issue 27, pages 15530-15535, July.
  2. Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2020, "Innovation and Corporate Dynamics: A Theoretical Framework," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, volume 12, issue 1, pages 1-45, March.
  3. Alessandro Spelta & Andrea Flori & Nicolò Pecora & Sergey Buldyrev & Fabio Pammolli, 2020, "A behavioral approach to instability pathways in financial markets," Nature Communications, Nature, volume 11, issue 1, pages 1-9, December, DOI: 10.1038/s41467-020-15356-z.

2019

  1. Petersen, Alexander M. & Pan, Raj K. & Pammolli, Fabio & Fortunato, Santo, 2019, "Methods to account for citation inflation in research evaluation," Research Policy, Elsevier, volume 48, issue 7, pages 1855-1865, DOI: 10.1016/j.respol.2019.04.009.
  2. Frassi, Benedetta & Gnecco, Giorgio & Pammolli, Fabio & Wen, Xue, 2019, "Intragenerational redistribution in a funded pension system," Journal of Pension Economics and Finance, Cambridge University Press, volume 18, issue 2, pages 271-303, April.
  3. Righetto, Lorenzo & Spelta, Alessandro & Rabosio, Emanuele & Pammolli, Fabio, 2019, "Long-term correlations in short, non-stationary time series: An application to international R&D collaborations," Journal of Informetrics, Elsevier, volume 13, issue 2, pages 583-592, DOI: 10.1016/j.joi.2019.02.010.
  4. Auteri, M. & Guccio, C. & Pammolli, F. & Pignataro, G. & Vidoli, F., 2019, "Spatial heterogeneity in non-parametric efficiency: An application to Italian hospitals," Social Science & Medicine, Elsevier, volume 239, issue C, DOI: 10.1016/j.socscimed.2019.112544.

2018

  1. Giorgio Gnecco & Berna Tuncay & Fabio Pammolli, 2018, "A Comparison of Game-Theoretic Models for Parallel Trade," International Game Theory Review (IGTR), World Scientific Publishing Co. Pte. Ltd., volume 20, issue 03, pages 1-57, September, DOI: 10.1142/S0219198918500032.
  2. Pan, Raj K. & Petersen, Alexander M. & Pammolli, Fabio & Fortunato, Santo, 2018, "The memory of science: Inflation, myopia, and the knowledge network," Journal of Informetrics, Elsevier, volume 12, issue 3, pages 656-678, DOI: 10.1016/j.joi.2018.06.005.

2016

  1. Michele Bonollo & Irene Crimaldi & Andrea Flori & Laura Gianfagna & Fabio Pammolli, 2016, "Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data," Financial Markets and Portfolio Management, Springer;Swiss Society for Financial Market Research, volume 30, issue 4, pages 397-426, November, DOI: 10.1007/s11408-016-0275-7.
  2. Jing-Yuan Chiou & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2016, "Learning from successes and failures in pharmaceutical R&D," Journal of Evolutionary Economics, Springer, volume 26, issue 2, pages 271-290, May, DOI: 10.1007/s00191-015-0439-z.
  3. Michelangelo Puliga & Andrea Flori & Giuseppe Pappalardo & Alessandro Chessa & Fabio Pammolli, 2016, "The Accounting Network: How Financial Institutions React to Systemic Crisis," PLOS ONE, Public Library of Science, volume 11, issue 10, pages 1-14, October, DOI: 10.1371/journal.pone.0162855.

2015

  1. Morescalchi, Andrea & Pammolli, Fabio & Penner, Orion & Petersen, Alexander M. & Riccaboni, Massimo, 2015, "The evolution of networks of innovators within and across borders: Evidence from patent data," Research Policy, Elsevier, volume 44, issue 3, pages 651-668, DOI: 10.1016/j.respol.2014.10.015.

2014

  1. Fabio Pammolli, 2014, "On Innovation, Instability, and Growth. A Review and an Interpretative Framework," Economia politica, Società editrice il Mulino, issue 1, pages 17-32.
  2. Fabio Pammolli & Gianluca Baio & Armando Rungi, 2014, "The price of pharmaceutical products in Italy. On some recent trends," Mercato Concorrenza Regole, Società editrice il Mulino, issue 2, pages 265-282.

2012

  1. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2012, "The sustainability of European health care systems: beyond income and aging," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 13, issue 5, pages 623-634, October, DOI: 10.1007/s10198-011-0337-8.

2011

  1. Fabio Pammolli & Nicola C. Salerno, 2011, "La distribuzione dei farmaci tra progetti di riforma e incertezze," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, volume 2011, issue 2, pages 125-148.

2009

  1. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009, "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, volume 18, issue 5, pages 467-486, DOI: 10.1080/10438590802547183.
  2. Ashish Arora & Alfonso Gambardella & Laura Magazzini & Fabio Pammolli, 2009, "A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development," Management Science, INFORMS, volume 55, issue 10, pages 1638-1653, October, DOI: 10.1287/mnsc.1090.1055.

2008

  1. Growiec, Jakub & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene, 2008, "On the size distribution of business firms," Economics Letters, Elsevier, volume 98, issue 2, pages 207-212, February.

2007

  1. Sergey V. Buldyrev & Jakub Growiec & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2007, "The Growth of Business Firms: Facts and Theory," Journal of the European Economic Association, MIT Press, volume 5, issue 2-3, pages 574-584, 04-05.
  2. S. V. Buldyrev & F. Pammolli & M. Riccaboni & K. Yamasaki & D.-F. Fu & K. Matia & H. E. Stanley, 2007, "A generalized preferential attachment model for business firms growth rates," The European Physical Journal B: Condensed Matter and Complex Systems, Springer;EDP Sciences, volume 57, issue 2, pages 131-138, May, DOI: 10.1140/epjb/e2007-00165-8.

2005

  1. Merito, Monica & Bonaccorsi, Andrea & Pammolli, Fabio & Riccaboni, Massimo & Baio, Gianluca & Arici, Claudio & Monforte, Antonella D'Arminio & Pezzotti, Patrizio & Corsini, Dario & Tramarin, Andrea & , 2005, "Economic evaluation of HIV treatments: The I.CO.N.A. cohort study," Health Policy, Elsevier, volume 74, issue 3, pages 304-313, November.
  2. Maria Alessandra Rossi & Fabio Pammolli, 2005, "Intellectual property, technological regimes and market dynamics," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, volume 2005, issue 2.

2004

  1. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2004, "Dynamic competition in pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 5, issue 2, pages 175-182, May, DOI: 10.1007/s10198-003-0218-x.

2003

  1. De Fabritiis, G. & Pammolli, F. & Riccaboni, M., 2003, "On size and growth of business firms," Physica A: Statistical Mechanics and its Applications, Elsevier, volume 324, issue 1, pages 38-44, DOI: 10.1016/S0378-4371(03)00043-8.

2002

  1. Riccaboni, Massimo & Pammolli, Fabio, 2002, "On firm growth in networks," Research Policy, Elsevier, volume 31, issue 8-9, pages 1405-1416, December.
  2. Pammolli, Fabio & Riccaboni, Massimo, 2002, "Technological Regimes and the Growth of Networks: An Empirical Analysis," Small Business Economics, Springer, volume 19, issue 3, pages 205-215, November.
  3. Fabio Pammolli & Laura Magazzini & Luigi Orsenigo, 2002, "The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis," Revue d'Économie Industrielle, Programme National Persée, volume 99, issue 1, pages 107-131, DOI: 10.3406/rei.2002.1829.
  4. Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002, "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, volume 48, issue 1, pages 24-43, January, DOI: 10.1287/mnsc.48.1.24.14275.

2001

  1. Bottazzi, Giulio & Dosi, Giovanni & Lippi, Marco & Pammolli, Fabio & Riccaboni, Massimo, 2001, "Innovation and corporate growth in the evolution of the drug industry," International Journal of Industrial Organization, Elsevier, volume 19, issue 7, pages 1161-1187, July.
  2. Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001, "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, volume 30, issue 3, pages 485-508, March.

1997

  1. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni & Andrea Bonaccorsi & Giuseppe Turchetti, 1997, "The Evolution of Knowledge and the Dynamics of an Industry Network," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), volume 1, issue 2, pages 147-175, June, DOI: 10.1023/A:1009991701667.

1996

  1. Bonaccorsi, Andrea & Pammolli, Fabio & Tani, Simone, 1996, "The changing boundaries of system companies," International Business Review, Elsevier, volume 5, issue 6, pages 539-560, December.

Books

2021

  1. Aldo Geuna & Marco Guerzoni & Massimiliano Nuccio & Fabio Pammolli & Armando Rungi, 2021, "Resilience and Digital Disruption," SpringerBriefs in Business, Springer, number 978-3-030-85158-3, ISBN: ARRAY(0x76553158), January, DOI: 10.1007/978-3-030-85158-3.

2020

  1. Buldyrev,S. V. & Pammolli,F. & Riccaboni,M. & Stanley,H. E., 2020, "The Rise and Fall of Business Firms," Cambridge Books, Cambridge University Press, number 9781107175488.

Chapters

2021

  1. Aldo Geuna & Marco Guerzoni & Massimiliano Nuccio & Fabio Pammolli & Armando Rungi, 2021, "The Way Ahead Towards Advanced Automation: Policy Implication for Core Italian Manufacturing Regions," SpringerBriefs in Business, Springer, chapter 0, "Resilience and Digital Disruption", DOI: 10.1007/978-3-030-85158-3_5.
  2. Aldo Geuna & Marco Guerzoni & Massimiliano Nuccio & Fabio Pammolli & Armando Rungi, 2021, "Digital Manufacturing and the Transformation of the Automotive Industry," SpringerBriefs in Business, Springer, chapter 0, "Resilience and Digital Disruption", DOI: 10.1007/978-3-030-85158-3_4.
  3. Aldo Geuna & Marco Guerzoni & Massimiliano Nuccio & Fabio Pammolli & Armando Rungi, 2021, "Participation in Global Supply Chains and the Offshorability of Italian Jobs," SpringerBriefs in Business, Springer, chapter 0, "Resilience and Digital Disruption", DOI: 10.1007/978-3-030-85158-3_3.
  4. Aldo Geuna & Marco Guerzoni & Massimiliano Nuccio & Fabio Pammolli & Armando Rungi, 2021, "Introduction," SpringerBriefs in Business, Springer, chapter 0, "Resilience and Digital Disruption", DOI: 10.1007/978-3-030-85158-3_1.
  5. Aldo Geuna & Marco Guerzoni & Massimiliano Nuccio & Fabio Pammolli & Armando Rungi, 2021, "Digital Technologies and Industrial Transformations," SpringerBriefs in Business, Springer, chapter 0, "Resilience and Digital Disruption", DOI: 10.1007/978-3-030-85158-3_2.

2003

  1. Massimo Riccaboni & Jason Owen-Smith & Walter W. Powell & Fabio Pammolli, 2003, "Public Research and Industrial Innovation: A Comparison of US and European Innovation Systems in the Life Sciences," Chapters, Edward Elgar Publishing, chapter 6, in: Aldo Geuna & Ammon J. Salter & W. Edward Steinmueller, "Science and Innovation".
  2. Fabio Pammolli & Massimo Riccaboni, 2003, "Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry," Chapters, Edward Elgar Publishing, chapter 2, in: Pier Paolo Saviotti, "Applied Evolutionary Economics".

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.